A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

NCT05428345 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease (IBD)

Sponsor

Takeda